Viral vector company Sirion opening Boston office; Jon Rees steps down at OBN;

@FierceBiotech: With IPO in mind, cancer player CytomX steps up with a $70M round. News | Follow @FierceBiotech

@JohnCFierce: Deputy at China agency that probed GSK arrested for corruption, report says. FiercePharmaAsia article | Follow @JohnCFierce

@DamianFierce: And hey $AGN's spending $2.1B on $KYTH and its chin-fat-reducing injection. Release | Follow @DamianFierce

> The viral vector platform company Sirion, based in Munich, plans to open an office in the Boston/Cambridge biotech hub. Release

> Jon Rees is stepping down as executive director of OBN, a biotech trade group that sponsors the annual BioTrinity meeting in the U.K. Release

Medical Device News

@FierceMedDev: ICYMI yesterday: Sweden's Elekta hits Varian Medical with patent suit over cancer care devices. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Alcon gets CE mark to sell new intraocular lens in Europe. Report | Follow @VarunSaxena2

@EmilyWFierce: "You're a regulator. Regulate." NYT story | Follow @EmilyWFierce

> HeartWare, hit with its fifth Class 1 recall of 2015, will replace defective blood pump controllers. Story

> Irish startup Neuravi raises $21M to get stroke stent retrieval device through pivotal trial. News

Pharma News

@FiercePharma: Why The Trans Fat Ban and Labels On Salt And Soda Won't Make Us Healthier. More from Forbes | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Bad news for AbbVie: Humira copies expected to rack up biggest biosim sales. Article | Follow @CarlyHFierce

> FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market. Story

> Allergan extends deal spree with $2.1B Kythera buyout. News

Biotech Research News

> New tool for brown fat drug development research. Item

> Harvard team transplants circadian wiring, pointing to new drug applications. More

> Scripps spotlights PPARy inhibitor as a potential drug for bone loss. Article

> Preclinical trials show ALK1 inhibitor dalantercept may prevent metastasis. Story

> New study will test feds' support for anti-aging drug research. Report

Diagnostics News

> Welch Allyn sells out to Hill-Rom for $2.05B. Item

> OraSure to receive up to $10M from feds to develop rapid Ebola test. More

> Ariosa Diagnostics scores CE mark for prenatal test software. News

> Sequenom slapped down in prenatal testing patent battle with Ariosa. Story

> Illumina teams up with Chinese genomics firm for noninvasive prenatal test development. Article

Pharma Marketing News

> Taking the guesswork out of sales, predictive analytics could lead way to improved pharma rep decisions. Article

> Astellas, Medivation to amp up unbranded Xtandi marketing for pre-chemo use. Report

> Good news for drug reps: Pay is growing again. Bad? Biotech outclasses pharma by 36%. More

> Ready to prescribe PCSK9 meds? Doctors say yes, yes, yes. Story

> Shire's Vyvanse could bag another lucrative new market in menopausal women. Article